---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002862"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:51:40.264117+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Anebulo shareholders approve authorized share increase to 75M, stock plan expansion, and removal of 10.1M-share lock-up

## Summary
- Authorized common stock increased from 50M to 75M shares; stock incentive plan pool raised by 2.5M to 6.15M shares.
- Voting and transfer restrictions on 10,101,010 shares held by 22NW Fund, LP removed per shareholder approval.
- Class I directors Joseph F. Lawler, Richard Anthony Cunningham, Aron R. English re-elected.
- Ratification of EisnerAmper LLP as independent auditor for fiscal 2025 approved.
- All proposals passed with strong majorities; record date had 41,084,731 shares outstanding.

## SEC filing metadata
- accession: 0001641172-25-002862
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000164117225002862/0001641172-25-002862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000164117225002862/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002862
- JSON: https://secwatch.observer/filing/0001641172-25-002862.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.